The patent covers the therapeutic use of adipose-derived stem and regeneration cells for repair and regeneration of the spinal disc as well as formation of bone, cartilage, skeletal muscle, tendon and ligaments. The patent includes several elements, such as 61 dependent claims covering the site of cell delivery, additives to the system’s output, surgical implants, scaffolds and spinal fusion devices for use with the system’s output.
This is the tenth U.S. patent issued to Cytori Therapeutics, which has more than 100 patent applications pending worldwide.
Read more about the Celution System patent.
Read other coverage on spine technology:
– Spine Education Labs Critical in Training for Cutting-Edge Procedures
– Spine Assist Surgical Robot Pre-Surgery Planning Device Available in Texas
– Spine Cell Treatment Center Opens in Texas
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.